🕵️ Scribe Therapeutics, Inc. ($SCTX)
SEC insider & ownership activity, last 12 months · CIK 1853921 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
6 buyers, value withheld pending verification (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Aghazadeh Behzad | 3 | $36.3M | 0 | – | Jul 28, 2026 |
| Orbimed Advisors LLC | 1 | $15.0M | 0 | – | Jul 27, 2026 |
| Carl L. Gordon | 1 | $15.0M | 0 | – | Jul 27, 2026 |
| AH BIO Fund II, L.P. | 1 | $5.0M | 0 | – | Jul 27, 2026 |
| Lucas Svetlana | 1 | value withheld pending verification | 0 | – | Jul 23, 2026 |
| Parrot David | 2 | value withheld pending verification | 0 | – | Jul 23, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Aghazadeh Behzad | 16.4% | 13D | Jul 24, 2026 | filing ↗ | |
| Avoro Capital Advisors LLC | 13.8% | 13D | Jul 24, 2026 | filing ↗ | |
| RA Capital Management, L.P. | 9.6% | 13G | Aug 3, 2026 | filing ↗ | |
| Peter Kolchinsky | 9.6% | 13G | Aug 3, 2026 | filing ↗ | |
| Rajeev Shah | 9.6% | 13G | Aug 3, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 9.1% | 13G | Aug 3, 2026 | filing ↗ | |
| ELI Lilly & Co | 7.3% | 13D | Jul 23, 2026 | filing ↗ | |
| Orbimed Advisors LLC | 7.2% | 13D | Jul 27, 2026 | filing ↗ | |
| Orbimed Capital GP VIII LLC | 7.2% | 13D | Jul 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Sep 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 2, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 27, 2026 | filing ↗ |